↓ Skip to main content

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Overview of attention for article published in New England Journal of Medicine, November 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Citations

dimensions_citation
1741 Dimensions

Readers on

mendeley
615 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Published in
New England Journal of Medicine, November 2012
DOI 10.1056/nejmoa1206797
Pubmed ID
Authors

Gregory G Schwartz, Anders G Olsson, Markus Abt, Christie M Ballantyne, Philip J Barter, Jochen Brumm, Bernard R Chaitman, Ingar M Holme, David Kallend, Lawrence A Leiter, Eran Leitersdorf, John J V McMurray, Hardi Mundl, Stephen J Nicholls, Prediman K Shah, Jean-Claude Tardif, R Scott Wright

Abstract

In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events. However, whether raising HDL cholesterol levels therapeutically reduces cardiovascular risk remains uncertain. Inhibition of cholesteryl ester transfer protein (CETP) raises HDL cholesterol levels and might therefore improve cardiovascular outcomes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 86 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 615 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 <1%
Netherlands 2 <1%
Brazil 2 <1%
Spain 2 <1%
Israel 1 <1%
Mexico 1 <1%
Switzerland 1 <1%
Japan 1 <1%
United Kingdom 1 <1%
Other 0 0%
Unknown 600 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 87 14%
Researcher 87 14%
Student > Bachelor 72 12%
Student > Master 66 11%
Other 52 8%
Other 130 21%
Unknown 121 20%
Readers by discipline Count As %
Medicine and Dentistry 244 40%
Biochemistry, Genetics and Molecular Biology 51 8%
Agricultural and Biological Sciences 50 8%
Pharmacology, Toxicology and Pharmaceutical Science 30 5%
Nursing and Health Professions 18 3%
Other 73 12%
Unknown 149 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 165. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2024.
All research outputs
#250,236
of 26,017,215 outputs
Outputs from New England Journal of Medicine
#4,436
of 32,765 outputs
Outputs of similar age
#1,249
of 203,975 outputs
Outputs of similar age from New England Journal of Medicine
#47
of 389 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,975 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 389 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.